Preparation method of oral egg yolk antibody for preventing and treating avian influenza
By combining hydroxypropyl methylcellulose solution with high-free eggs and adding sulfaluminum, chitosan, trehalose, sorbitol, the extraction process of yolk antibodies is simplified, solving the complex and cost of operation in the prior art. The high problem achieves efficient and low-cost antibody preparation, and extends the effectiveness of the antibody through the sustained release mechanism, ensuring the antibacterial and anticorrosive effect.
Patent Information
- Application Number
- CN202411081418.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing yolk antibody extraction methods have problems such as complex operation, high cost, environmental pollution, affected antibody activity and residual proteins. The centrifugation process is prone to pollution, and the antibody recovery loss is large.
Using hydroxypropyl methylcellulose solution to combine with high-free eggs, the efficient oral yolk antibody liquid is prepared by adjusting the pH value and adding sulfaluminum, chitosan, trehalose, and sorbitol, which simplifies operation and reduces costs. and prolong the effectiveness of the antibody through sustained release mechanism.
It achieves simple operation, high production efficiency, low cost, high antibody titer and large yield, avoids injection immune stress, prolongs the effectiveness of the effective ingredient of the antibody, and ensures antibacterial and anti-corrosion effects through a sustained release mechanism.
Smart Images

Figure CN118987202A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of egg yolk antibody preparation, in particular to a method for preparing an oral egg yolk antibody for preventing and treating avian influenza. Background Art
[0002] Yolk antibodies refer to antibodies present in the yolk of poultry after immunization. They are antibodies that are transferred from specific antibodies (IgG, IgA, IgM, etc.) in the blood of poultry to the yolk to produce a protective effect on the offspring. Commonly used methods for extracting yolk antibodies include polyethylene glycol precipitation, cold ethanol method, ammonium sulfate precipitation method, caprylic acid method or chloroform organic solvent extraction method and acidified water extraction method. There is no reliable method to remove polyethylene glycol after it is dissolved in water, and its residue may cause harm to livestock and poultry, and the dosage is large and the cost is high. The antibodies extracted by the cold ethanol method have a higher purity, but the protein is easy to denature during the operation and needs to be carried out at low temperature. There are also problems with organic solvent residues and cumbersome multi-step centrifugation operations. The ammonium sulfate precipitation method can effectively remove the impurities in the yolk antibody. It has the advantages of low production cost, low environmental pollution, high antibody recovery rate and good purity, low requirements for equipment and conditions, low price of ammonium sulfate, and mild nature. The disadvantage is that the amount of ammonium sulfate used is too large and the buffering capacity is poor, which affects the activity of the yolk antibody, and a large amount of ammonium sulfate waste liquid causes environmental pollution. The organic solvent extraction method such as caprylic acid or chloroform, this method The organic solvent not only affects the activity of the antibody, but is also toxic and pollutes the environment. The acidified water extraction method, in an acidic pH and low concentration of ions, the lipoprotein in the yolk condenses and precipitates to achieve the purpose of separating and extracting the yolk antibody. This method has a large loss of yolk antibodies, and the acidified water stabilization system is poor, and there is a problem that the shelf life of the extracted yolk antibody is short. All of the above methods require the centrifugation process, which is prone to pollution, and the antibody recovery will be lost.
[0003] In view of the above problems, the present invention is proposed. Summary of the invention
[0004] In order to overcome the above-mentioned defects in the prior art, the present invention provides a method for preparing oral egg yolk antibodies for preventing and treating avian influenza.
[0005] A method for preparing an oral egg yolk antibody for preventing and treating avian influenza comprises the following steps:
[0006] S1, preparation of egg yolk antibody solution;
[0007] S2, preparing oral egg yolk antibody: the effective component of the oral egg yolk antibody is prepared from 70-85 parts of egg yolk antibody liquid, 5-10 parts of sucralfate, 5-10 parts of chitosan, 5-10 parts of trehalose, and 0.1 parts of sorbitol;
[0008] In S1, the egg yolk antibody solution is prepared using a solution containing hydroxypropyl methylcellulose and a high-immune egg yolk stock solution.
[0009] Furthermore, the concentration of the hydroxypropyl methylcellulose solution in step S1 is 0.6%
[0010] Furthermore, the highly immune eggs in step S1 are eggs laid by laying hens immunized with an inactivated avian influenza vaccine.
[0011] Furthermore, in step S1, the highly immune eggs are placed in a 0.1% chlorhexidine solution for disinfection for 15 minutes, the surface moisture is dried, and the egg white and placenta are removed by a separator to obtain the yolk stock solution.
[0012] Furthermore, in the step S1, the hydroxypropyl methylcellulose solution and the egg yolk stock solution are fully mixed, and the pH value is adjusted to 4.9-5.1, and the supernatant is taken after standing to obtain the egg yolk antibody solution.
[0013] Furthermore, in step S2, sucralfate, chitosan, trehalose and sorbitol are added to the egg yolk antibody solution and stirred with a mixer at room temperature for 1 hour. After quantitative packaging, the solution is stored at 2-8°C.
[0014] Furthermore, the effective ingredient of the oral egg yolk antibody in step S2 is prepared from 85 parts of egg yolk antibody liquid, 5 parts of sucralfate, 5 parts of chitosan, 5 parts of trehalose, and 0.1 parts of sorbitol.
[0015] The beneficial technical effects of the present invention are:
[0016] 1. The preparation method of the egg yolk antibody provided by the present invention is simple to operate, has high production efficiency and low production cost, and the obtained egg yolk antibody has high titer and large yield, can replace the existing antibody extraction process, and has good promotion value.
[0017] 2. The hydroxypropyl methylcellulose solution used in the present invention uses a small amount of reagent, reduces the cost of reagent use, leaves no residue, has no toxic side effects on animals, does not produce harmful substances, and the yolk residue produced in the preparation process of the yolk antibody solution can be used for fermentation and recycled.
[0018] 3. The method for preparing oral egg yolk antibodies provided by the present invention solves the stress stimulation of injection immunization and avoids the adverse reactions of animals caused by injection immunization stress.
[0019] 4. The preparation method of the oral egg yolk antibody provided by the present invention protects the antibody from being decomposed and destroyed by gastric acid and pepsin in the digestive tract after adding sucralfate, chitosan, trehalose and sorbitol, while achieving the sustained release of effective substances, prolonging the efficacy test of the effective ingredients of the antibody, and ensuring the antibacterial and preservative effect of the oral egg yolk antibody. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1This is a graph showing the experimental results of the preventive effect of the oral yolk antibody of the present invention;
[0021] Figure 2 This is a graph showing the results of an experiment on the therapeutic effect of oral yolk antibodies of the present invention. DETAILED DESCRIPTION
[0022] In order to more clearly illustrate the technical solution of the present invention, the present invention is further described below in conjunction with the accompanying drawings. Obviously, the accompanying drawings described below are only one embodiment of the present invention. For ordinary technicians in this field, without paying any creative work, other embodiments can be obtained based on this drawing and embodiment, which all belong to the protection scope of the present invention.
[0023] Example 1
[0024] The invention discloses a method for preparing an oral egg yolk antibody for preventing and treating bird flu. The effective components of the egg yolk antibody are as follows: 70 parts of egg yolk antibody liquid containing bird flu egg yolk antibody, 10 parts of sucralfate, 10 parts of chitosan, 10 parts of trehalose and 0.1 parts of sorbitol. Chitosan, trehalose and sorbitol are added to the egg yolk antibody liquid, stirred for 1 hour with a stirrer at room temperature, quantitatively packaged, sealed with a cover and stored at 2-8 DEG C to obtain the oral egg yolk antibody.
[0025] The preparation steps of the yolk antibody solution are as follows:
[0026] (1) Prepare hydroxypropyl methylcellulose solution: add 6 g of hydroxypropyl methylcellulose to 1000 ml of purified water and mix thoroughly to dissolve;
[0027] (2) using avian influenza highly immune eggs, placing the highly immune eggs in a 0.1% chlorhexidine solution for 15 minutes for disinfection, drying the surface moisture, removing the egg white and placenta with a separator, collecting the yolk stock solution and stirring it thoroughly;
[0028] (3) Take 250 ml of the hydroxypropyl methylcellulose solution in step (1), add 50 ml of the egg yolk stock solution, mix thoroughly to obtain an egg yolk mixed solution, and adjust the pH to 5.0 using 0.1 M HCl;
[0029] (4) The egg yolk mixture is allowed to stand at room temperature for 16-24 hours, the supernatant is collected, and filtered through a 0.22 μm filter to obtain the egg yolk antibody solution.
[0030] Example 2
[0031] The invention discloses a method for preparing an oral egg yolk antibody for preventing and treating bird flu. The effective components of the egg yolk antibody are as follows: 80 parts of egg yolk antibody liquid containing bird flu egg yolk antibody, 5 parts of sucralfate, 5 parts of chitosan, 10 parts of trehalose and 0.1 parts of sorbitol. Chitosan, trehalose and sorbitol are added to the egg yolk antibody liquid, stirred at room temperature for 1 hour, quantitatively packaged, sealed with a cover and stored at 2-8 DEG C to obtain the oral egg yolk antibody.
[0032] The preparation steps of the yolk antibody solution are as follows:
[0033] (1) Prepare hydroxypropyl methylcellulose solution: add 6 g of hydroxypropyl methylcellulose to 1000 ml of purified water and mix thoroughly to dissolve;
[0034] (2) using avian influenza highly immune eggs, placing the highly immune eggs in a 0.1% chlorhexidine solution for 15 minutes for disinfection, drying the surface moisture, removing the egg white and placenta with a separator, collecting the yolk stock solution and stirring it thoroughly;
[0035] (3) Take 250 ml of the hydroxypropyl methylcellulose solution in step (1), add 50 ml of the egg yolk stock solution, mix thoroughly to obtain an egg yolk mixed solution, and adjust the pH to 5.0 using 0.1 M HCl;
[0036] (4) The egg yolk mixture is allowed to stand at room temperature for 16-24 hours, the supernatant is collected, and filtered through a 0.22 μm filter to obtain the egg yolk antibody solution.
[0037] Example 3
[0038] The invention discloses a method for preparing an oral egg yolk antibody for preventing and treating bird flu. The effective components of the egg yolk antibody are as follows: 85 parts of egg yolk antibody liquid containing bird flu egg yolk antibody, 5 parts of sucralfate, 5 parts of chitosan, 5 parts of trehalose and 0.1 parts of sorbitol. Chitosan, trehalose and sorbitol are added to the egg yolk antibody liquid, stirred at room temperature for 1 hour, quantitatively packaged, sealed with a cover and stored at 2-8 DEG C to obtain the oral egg yolk antibody.
[0039] The preparation steps of the yolk antibody solution are as follows:
[0040] (1) Prepare hydroxypropyl methylcellulose solution: add 6 g of hydroxypropyl methylcellulose to 1000 ml of purified water and mix thoroughly to dissolve;
[0041] (2) using avian influenza highly immune eggs, placing the highly immune eggs in a 0.1% chlorhexidine solution for 15 minutes for disinfection, drying the surface moisture, removing the egg white and placenta with a separator, collecting the yolk stock solution and stirring it thoroughly;
[0042] (3) Take 250 ml of the hydroxypropyl methylcellulose solution in step (1), add 50 ml of the egg yolk stock solution, mix thoroughly to obtain an egg yolk mixed solution, and adjust the pH to 5.0 using 0.1 M HCl;
[0043] (4) The egg yolk mixture is allowed to stand at room temperature for 16-24 hours, the supernatant is collected, and filtered through a 0.22 μm filter to obtain the egg yolk antibody solution.
[0044] Example 4 Preparation of oral yolk antibody status and antibody titer detection
[0045] (1) Detection of the status of oral egg yolk antibodies: The turbidity of the finished oral egg yolk antibodies obtained by the preparation methods of Examples 1-3 was tested to see whether there was precipitation. The results are shown in Table 1. After the oral egg yolk antibodies were allowed to stand for 16-24 hours, the clarity of the oral egg yolk antibodies and whether there was precipitation were observed with the naked eye. As can be seen from Table 1, the oral egg yolk antibodies obtained by the preparation method of Example 3 had high clarity and no precipitation.
[0046] (2) Detection of the titer of oral egg yolk antibodies: The oral egg yolk antibodies obtained by the preparation methods of Examples 1-3 were subjected to titer detection. The results are shown in Table 1. The avian influenza titer of the antibody oral solution was detected using a hemagglutination inhibition test (HI). As can be seen from Table 1, the titer of the oral egg yolk antibodies obtained by the preparation method of Example 3 was higher.
[0047] Based on the results of Examples 1-3, different ratios of egg yolk antibody liquid, chitosan and trehalose have a great influence on the state and potency of the finished oral egg yolk antibody. In Example 1, 70 parts of egg yolk antibody liquid, 10 parts of sucralfate, 10 parts of chitosan, 10 parts of trehalose and 0.1 parts of sorbitol are added. The finished oral egg yolk antibody is turbid, precipitates are formed, and the antibody potency is reduced. Relative to Example 1, in Example 3, the ratio of sucralfate, chitosan and trehalose is halved, and the preparation ratio of egg yolk antibody liquid, sucralfate, chitosan, trehalose and sorbitol is adjusted to 85:5:5:5:0.1. The finished product is clear, has no precipitate, and has the same potency as the egg yolk antibody liquid. The results show that when the effective ingredients of oral egg yolk antibodies are prepared from 85 parts of egg yolk antibody liquid, 5 parts of sucralfate, 5 parts of chitosan, 5 parts of trehalose and 0.1 parts of sorbitol, there is no precipitate. The oral egg yolk antibody liquid is centrally distributed to the chickens through the drinking water pipeline system without problems such as pipe blockage and uneven distribution. The antibody titer of the oral antibody liquid is stable and not lost.
[0048] Table 1 Finished product status and potency test results of components in different proportions
[0049]
[0050] Example 5 Application of Oral Yolk Antibody
[0051] (1) Experimental study on the preventive effect of oral yolk antibodies
[0052] Thirty 28-day-old SPF breeder chickens were selected and randomly divided into three groups, with 10 chickens in each group. In the first group, each breeder chicken took 2 ml of yolk antibody orally every day for two consecutive days. The oral yolk antibody was the oral yolk antibody obtained by the preparation method of Examples 1-3. In the second group, each breeder chicken took 2 ml of yolk antibody liquid every day for two consecutive days. The yolk antibody liquid was the yolk antibody liquid obtained by the preparation method of Examples 1-3. The third group was the challenge control group. On the third day, each breeder chicken in the first, second and third groups was challenged with 0.2 ml of avian influenza virus liquid by eye drops and nasal drops. The avian influenza virus content in each 0.2 ml was 10 6.0 EID 50 On the 3rd and 7th days after the challenge, the throat and cloacal cotton swabs were collected from the first, second and third groups of breeders for quantitative fluorescence PCR. Figure 1 It can be seen that 3 and 7 days after the breeder chickens were infected with the virus, the detection showed that the amount of toxin excretion in the first and second groups showed a significant downward trend, and the amount of toxin excretion in the first group on the seventh day was significantly less than that in the second group on the seventh day.
[0053] (2) Experimental study on the therapeutic effect of oral yolk antibodies
[0054] Thirty 28-day-old SPF breeder chickens were randomly divided into three groups, with 10 chickens in each group. Each chicken in each group was challenged with 0.2 ml of avian influenza virus solution by eye and nose drops, with each 0.2 ml containing 10 6.0 EID 50 , 12 hours and 36 hours after the challenge, the first group of breeder chickens took oral yolk antibodies, the second group of breeder chickens took oral yolk antibody liquid, and the third group of breeder chickens served as the challenge control group, wherein the oral yolk antibodies and yolk antibody liquid were obtained by the preparation method of Examples 1-3. On the 3rd and 7th days after the challenge, the laryngeal and cloacal cotton swabs were collected from the first, second and third groups of breeder chickens for fluorescent quantitative PCR. Figure 2 It can be seen that 3 and 7 days after the breeder chickens were infected with the virus, the detection showed that the amount of toxin excretion in the first and second groups showed a significant downward trend, and the amount of toxin excretion in the first group on the seventh day was significantly less than that in the second group on the seventh day.
[0055] In summary, the breeding chickens that orally take the egg yolk antibody liquid obtained by the preparation method of Examples 1-3 can reduce the excretion of viruses in the prevention and treatment of avian influenza. The oral egg yolk antibodies obtained by the preparation method of Examples 1-3 can reduce the excretion of viruses in the prevention and treatment of avian influenza. In terms of the prevention and treatment effect of avian influenza, the toxin excretion of the oral egg yolk antibody group on the seventh day was significantly less than that of the oral egg yolk antibody liquid group. Therefore, the prevention and treatment of avian influenza by taking oral egg yolk antibodies is more effective and has stronger protection for animals.
[0056] Based on the results of the embodiment, different ratios of egg yolk antibody liquid, chitosan and trehalose have a great influence on the state and potency of the finished oral egg yolk antibody. The effective ingredients of the oral egg yolk antibody are prepared from 85 parts of egg yolk antibody liquid, 5 parts of sucralfate, 5 parts of chitosan, 5 parts of trehalose and 0.1 parts of sorbitol. There is no precipitate. The antibody oral liquid is concentrated in the chickens through the drinking water pipeline system, and there will be no problems such as pipeline blockage and uneven delivery. The antibody potency of the antibody oral liquid is stable and not lost.
[0057] The present invention uses hydroxypropyl methylcellulose solution to extract egg yolk antibodies. The hydroxypropyl methylcellulose has good stability, is relatively stable to both acid and alkali, has anti-mildew effect, can be stored for a long time, has viscosity, can be combined with lipoprotein in egg yolk, can better extract antibodies, can reduce the centrifugation process, has good film-forming property, can wrap antibodies and slowly release them in the body, has good safety, is non-toxic and non-irritating, uses a small amount of hydroxypropyl methylcellulose solution, reduces the cost of reagent use, and the egg yolk residue generated in the preparation process of the egg yolk antibody solution can be used for fermentation, recycling and reuse;
[0058] The method for preparing the oral yolk antibody provided by the present invention solves the stress stimulation of injection immunization and avoids the adverse reaction of animals caused by the injection immunization stress.
[0059] The invention provides a method for preparing an oral egg yolk antibody. Sucralfate, chitosan, trehalose and sorbitol are added. Sucralfate is used as a protective agent for the egg yolk antibody, which can not only reduce the destructive effect of gastric acid and pepsin on the egg yolk antibody, but also play a protective effect of sucralfate itself on the gastric mucosa, and is a relatively ideal egg yolk antibody protective agent. Chitosan, as a carrier, can stabilize the components in the antibody, promote antibody absorption, delay antibody decomposition, and has acid resistance to prevent irritation to the stomach. Trehalose has a unique biological function, can maintain the stability and integrity of the antibody protein, maintain the natural structure of the antibody, prevent denaturation, and has good stability. Sorbitol has high antibacterial performance, inhibits the growth and reproduction of bacteria, achieves the purpose of inhibiting the growth of microorganisms and plays an antiseptic role, and has an inhibitory effect on molds, yeasts and many aerobic bacteria. By adding sucralfate, chitosan, trehalose and sorbitol, the decomposition and destruction of the antibody by gastric acid and pepsin in the digestive tract is protected, and the sustained release of effective substances is achieved, the efficacy test of the effective components of the antibody is prolonged, and the antibacterial and antiseptic effect of the oral egg yolk antibody is guaranteed.
[0060] The above embodiments are only exemplary embodiments of the present invention and are not intended to limit the present invention. The protection scope of the present invention is defined by the claims. Those skilled in the art may make various modifications or equivalent substitutions to the present invention within the essence and protection scope of the present invention, and such modifications or equivalent substitutions shall also be deemed to fall within the protection scope of the present invention.
Claims
1. A method for preparing an oral egg yolk antibody for preventing and treating avian influenza, characterized in that: The steps include: S1, preparation of egg yolk antibody solution; S2, preparing oral egg yolk antibody: the effective component of the oral egg yolk antibody is prepared from 70-85 parts of egg yolk antibody liquid, 5-10 parts of sucralfate, 5-10 parts of chitosan, 5-10 parts of trehalose, and 0.1 parts of sorbitol; In step S1, the egg yolk antibody solution is prepared by using a solution containing hydroxypropyl methylcellulose and a high-immune egg yolk stock solution.
2. The method for preparing an oral egg yolk antibody for preventing and treating avian influenza according to claim 1, characterized in that: The concentration of the hydroxypropyl methylcellulose solution in step S1 is 0.6%.
3. The method for preparing an oral egg yolk antibody for preventing and treating avian influenza according to claim 1, characterized in that: The highly immune eggs in step S1 are eggs laid by laying hens immunized with inactivated avian influenza vaccine.
4. The method for preparing an oral egg yolk antibody for preventing and treating avian influenza according to claim 3, characterized in that: In step S1, the highly immune eggs are placed in a 0.1% chlorhexidine solution for disinfection for 15 minutes, the surface moisture is dried, and the egg white and placenta are removed by a separator to obtain the yolk stock solution.
5. The method for preparing an oral egg yolk antibody for preventing and treating avian influenza according to claim 1, characterized in that: In step S1, the hydroxypropyl methylcellulose solution and the egg yolk stock solution are fully mixed, and the pH value is adjusted to 4.9-5.
1. After standing, the supernatant is collected to obtain the egg yolk antibody solution.
6. The method for preparing an oral egg yolk antibody for preventing and treating avian influenza according to claim 1, characterized in that: In step S2, sucralfate, chitosan, trehalose and sorbitol are added to the egg yolk antibody solution and stirred with a mixer at room temperature for 1 hour. After quantitative packaging, the solution is stored at 2-8°C.
7. The method for preparing an oral egg yolk antibody for preventing and treating avian influenza according to claim 1, characterized in that: The effective component of the oral yolk antibody in step S2 is prepared from 85 parts of yolk antibody liquid, 5 parts of sucralfate, 5 parts of chitosan, 5 parts of trehalose, and 0.1 parts of sorbitol.
Citation Information
Patent Citations
High-stable anti-helicobacter pylori recombinant VacA specific egg yolk antibody and use thereof
CN101386649A
Avian influenza egg yolk antibody oral solution and preparation method thereof
CN104524572A
Method for preparing dry egg yolk antibody powder
CN107383189A
Preparation method of oral slow-release antibody for preventing and treating gosling plague
CN111150843A
Composite settling agent and method for efficiently extracting egg yolk antibody
CN113999300A
